GlassScriptPhysician profile
Radu Hagau
NPI 1073742144
$3,085.21
in general payments reported to CMS, 2019-2025
21 companies · $613 in 2025
The $613 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.85 · 2021: $1,922 · 2022: $77.09 · 2023: $64.23 · 2024: $397 · 2025: $613.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,075.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,074.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $1,013.79 | 2021 | |
| Ge Healthcare | $907.84 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $166.09 | 2023-2025 | Lifevest |
| Edwards Lifesciences Corporation | $132.85 | 2024 | |
| Novartis Pharmaceuticals Corporation | $106.99 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $103.30 | 2024-2025 | Farxiga, Wainua |
| Abbott Laboratories | $92.62 | 2023-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Amplatzer, Dragonfly Opstar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $84.53 | 2025 | Jardiance |
| Atricure, INC. | $77.09 | 2022 | |
| Pfizer INC. | $61.52 | 2024-2025 | |
| Bridgebio Pharma, INC. | $54.58 | 2025 | Attruby |
| Irhythm Technologies, INC. | $39.13 | 2024 | Zio Xt Patch, Zio Monitor |
| E.R. Squibb & Sons, L.L.C. | $38.81 | 2025 | Camzyos |
| Merck Sharp & Dohme LLC | $34.92 | 2024-2025 | Verquvo |
| Janssen Pharmaceuticals, INC | $32.80 | 2023-2024 | Xarelto |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $30.84 | 2024 | Watchman Flx |
| Bayer Healthcare Pharmaceuticals INC. | $30.50 | 2025 | |
| Heartflow, INC. | $22.22 | 2025 | |
| Teleflex LLC | $21.62 | 2025 | Supercross |
| Lexicon Pharmaceuticals, INC. | $17.70 | 2024 | |
| Amgen INC. | $15.47 | 2025 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Radu Hagau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.